Skip to content

Pilot: Use of Rotem in revisions of hip arthroplasties: Changes in coagulation parameters?

Pilot: Use of Rotem in revisions of hip arthroplasties: Changes in coagulation parameters? - Coagulation in revision surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON40640
Enrollment
15
Registered
2014-07-07
Start date
2014-02-11
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

blood coagulation fibrinogen

Interventions

None listed

Sponsors

Isala Klinieken
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: all patients, older than 18 years, who will receive a total hip revision operation

Exclusion criteria

Exclusion criteria: patient refusal

Design outcomes

Primary

MeasureTime frame
Changes in the Fibtem measurements of the Rotem

Secondary

MeasureTime frame
Changes in the other parameters of the Rotem measurements

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)